Viewing Study NCT00699166

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-02-04 @ 5:20 PM
Study NCT ID: NCT00699166
Status: COMPLETED
Last Update Posted: 2008-06-17
First Post: 2008-06-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Sponsor: Novartis
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Irritable Bowel Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None IBS View
None Diarrhea View
None gastrointestinal functional disorder View
None IBS-D View